Rhythm Pharmaceuticals (RYTM)'s 30-day implied volatility (IV30) was 57.4% at the close on November 6, 2026, up from 55.4% the day before, against a 52-week range of 36.1% to 105.9%. Its 20-day historical volatility was 38.6%.
Data as of November 6, 2026.